GlassScriptPhysician profile
Cara Geoca
NPI 1184398745
$2,375.42
in general payments reported to CMS, 2019-2025
19 companies · $827 in 2025
The $827 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $499 · 2023: $492 · 2024: $557 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,876.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $467.62 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $213.50 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $210.67 | 2023-2025 | |
| Astellas Pharma US INC | $190.63 | 2024-2025 | Veozah |
| Organon LLC | $163.95 | 2022 | |
| Myovant Sciences INC. | $161.85 | 2022 | |
| Coopersurgical, INC. | $142.50 | 2023-2025 | Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Biogen, INC. | $125.00 | 2025 | Zurzuvae |
| Abbvie INC. | $115.20 | 2022-2025 | |
| Evofem Biosciences, INC. | $108.71 | 2024-2025 | Solosec, Phexx, Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $101.21 | 2022-2025 | |
| Sage Therapeutics, LLC | $75.29 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $64.41 | 2022-2024 | Twirla |
| Exeltis, USA INC. | $63.61 | 2022-2025 | Slynd |
| Supernus Pharmaceuticals, INC. | $53.84 | 2025 | Qelbree |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $47.32 | 2023-2024 | |
| Avion Pharmaceuticals | $33.44 | 2023 | Balcoltra |
| Millicent US INC | $21.43 | 2025 | Intrarosa, Femlyv |
| Hologic Sales and Service, LLC | $15.24 | 2025 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Geoca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.